Maker of the first-and-only FDA-cleared prescription video game treatment joins the ranks of Canva, Microsoft, SpaceX, and more
Akili Interactive Labs, Inc. (“Akili”), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today announced it has been named to Fast Company’s prestigious list of the World’s Most Innovative Companies for 2022.
This year’s list honors businesses that are making the biggest impacts on their industries and culture as a whole and thriving in today’s ever-changing world. The companies included have been recognized for their contributions to some of the most inspiring accomplishments of the 21st century. To select the honorees, Fast Company’s editors and writers sought out the most groundbreaking businesses across the globe.
“We are honored to be recognized by Fast Company as one of the world’s most innovative companies. Akili was founded with a vision to create treatments that are both effective and enjoyable, ushering in a new category of medicine,” said Eddie Martucci, Co-Founder and Chief Executive Officer of Akili. “We’re committed to continuing to challenge the status quo by leveraging innovative technology to positively impact the millions of people living with cognitive impairments, as we reimagine what medicine should feel like.”
The World’s Most Innovative Companies is Fast Company’s signature franchise and one of its most highly anticipated editorial efforts of the year. It provides both a snapshot and a road map for the future of innovation across the most dynamic sectors of the economy.
“The world’s most innovative companies play an essential role in addressing the most pressing issues facing society, whether they’re fighting climate change by spurring decarbonization efforts, ameliorating the strain on supply chains, or helping us reconnect with one another over shared passions,” said Fast Company Deputy Editor David Lidsky.
Founded in 2011, Akili is developing digital prescription treatments to improve cognition, developed through a unique collaboration of cognitive neuroscientists and entertainment and technology designers. The Akili platform represents a fundamental paradigm shift where technology is the medicine, designed to target neural networks critical to cognitive function. The company aims to transform the user-friendly experiences of digital therapeutics into clinically-validated treatments for cognitive functions that are designed to be indistinguishable from high-end entertainment experiences. With this approach, in June 2020 Akili introduced the first prescription video game treatment for any disease cleared by the U.S. Food and Drug Administration (FDA) - a treatment focusing on attention function for children with attention-deficit/hyperactivity disorder (ADHD). In addition, Akili is progressing research across a diverse set of indications, including treatments for cognitive impairments associated with major depressive disorder, autism spectrum disorder and multiple sclerosis.
On January 26, 2022, Akili entered into a definitive agreement to become publicly traded via a merger with Social Capital Suvretta Holdings Corp. I (Nasdaq: DNAA), a special purpose acquisition company. The transaction is expected to close in mid-2022, subject to satisfaction of the closing conditions, after which Akili will be listed on the Nasdaq stock market under the new ticker symbol “AKLI.”
For the second year in a row, to coincide with the issue launch, Fast Company will host its Most Innovative Companies Summit on April 26–27. The virtual, multi-day summit celebrates the Most Innovative Companies in business and provides an early look at major business trends and an inside look at what it takes to innovate in 2022. Fast Company’s Most Innovative Companies issue (March/April 2022) is available online, as well as in-app form via iTunes, and on newsstands beginning March 15.
